The diagnosis of feline infectious peritonitis (FIP) is hampered by the characteristic etiopathogenesis of the disease. 9 The coronavirus responsible for the disease (FIPV) originated by a mutation in the widespread feline enteric coronavirus (FECV). 9,14 These coronaviruses are both phenotypically and genotypically identical, as demonstrated by polymerase chain reaction (PCR). 14 Both feline coronaviruses (FCoVs) are able to trigger the production of antibodies. High antiFCoV titers are also detectable in healthy cats in FECVendemic catteries, 9,10 and the formation of immune complexes could results in negative serology in symptomatic cats. 8 Furthermore, false-positive results occur from cross-reactivity with coronaviruses of other species, such as canine coronavirus (CCV) or transimissible gastroenteritis virus (TGEV), or with extraneous noncoronavirus proteins that are copurified with the FCoV and included in commercially available diagnostic enzyme-linked immunosorbent assay kits. 1 Hematology, serum chemistry, and serum protein electrophoresis give only a strongly suggestive but nonpathognomonic pattern of FIP. 9,12,13 In the effusive forms, diagnosis could be improved by cytology 3 and protein analysis of the fluid. 9,11-13 Although FCoV RNA has been demonstrated in the plasma of healthy cats in FECV-endemic catteries, 6 FCoVs detected from areas other than the intestinal lumen should be interpreted as FIPV, particularly if the viruses are detected in lesions 15 or effusions. 2 In this study, the results obtained using 3 different diagnostic methods (anti-FCoV direct immunofluorescence test, cytology, and protein analysis) for 110 cats with effusions over a 5-year period were compared to determine the utility of these methods for diagnosing FIP from analysis of the effusion alone. Cats with clinically detectable effusion were examined (Table 1), although in some cases clinical and laboratory data (serum chemistry, ultrasonography, macroscopic appearance of the effusion) suggested diseases other than FIP.Approximately 2 ml of effusion was withdrawn from each cat before death (72 cats) or within 2 hours after death (38 cats). The sampled fluid was put in a tube containing ethylenediamine tetraacetic acid. The protein content of the effusions of 51 cats was evaluated in a discrete autoanalyzer a by the biuret method. b Fifty to 100 l of fluid was cytocentrifuged c within 15 hours at 130 ϫ g for 10 minutes. Two Received for publication August 25, 1997.slides were obtained from each fluid sample; 1 slide was routinely stained with May Grünwald-Giemsa and the other was used immediately or after storage at Ϫ20 C for no more than 1 week for direct immunofluorescence (DIF) tests as previously described. 2 The slides were fixed and dehydrated in acetone : methanol (3:1) for 20 minutes and incubated for 30 minutes at 37 C in a moist chamber with 100 l of a feline polyclonal fluorescein-conjugated antiserum d detecting FCoV biotypes I and II and cross-reacting with TGEV and CCV. After washing 4 times for 10 minutes e...
Haematology, antibody titers and serum protein electrophoresis from 48 cats (34 effusive and 14 noneffusive forms) affected with feline infectious peritonitis (FIP) were studied and compared with those of 20 healthy cats. In the effusive form, antibody titers and protein electrophoresis in the effusions were analyzed. The distribution of the immune cells and of the virus in FIP lesions were also investigated immunohistochemically with the avidin-biotin complex (ABC) method, using antibodies against the FIP virus (FIPV), myelomonocytic (MAC387) and lymphoid (CD3, CD4 and CD8 for T-cells and IgM and IgG for B-cells) antigens. Seropositive animals (antibody titer>1:100) were present among both the FIP infected cats (73%) and the healthy cats (70%). Cats with effusive FIP had neutrophilic leukocytosis (P>0.05), lymphopenia (P<0.01) and eosinopenia (P<0.001). In both effusive and noneffusive forms decreased albumin/globulin ratio (P<0.001) with hypoalbuminemia (P<0.001), hyperglobulinemia (P<0.001) and increased alpha2- (P<0.05), beta- (P<0.05) and gamma-globulins (P<0.001) were found. Hypergammaglobulinemia was not related to the antibody titers, suggesting the presence of other proteins with gamma-motility (e.g. complement fractions). The electrophoretic pattern of the effusions was always similar to that of the corresponding serum. Antibody titers higher than those of the corresponding serum were often detected in the effusions. Immunohistochemical findings were not related to the antibody titers, but they were related to the histological aspect of the lesions. In cellular foci of FIP lesions many virus-infected macrophages and few lymphocytes, mainly CD4+, were found. Extracellular viral and myelomonocytic antigens were also detectable in the foci with intercellular necrosis. Only few FIPV-infected cells were present at the periphery of the larger necrotic foci: in these lesions MAC387+ cells were mainly neutrophils, with many MAC387 macrophages, probably due to their activated state; a small number of lymphocytes, with an increasing percentage of CD8+ cells was present. Lymphocytes were more abundant when cellular foci and FIP-infected macrophages were centered around neoformed vessels. IgM and IgG exposing B-cells were always few and scattered. In conclusion the simultaneous analysis of body fluids and of the cellular composition of the lesions showed a complex immune status, on which type III and type IV hypersensitivity could coexist.
Twenty‐one cases of feline infectious peritonitis (FIP) were diagnosed using a direct immunofluorescence test on cytocentrifuged pleural and peritoneal effusions from cats sampled in vivo (11 cases) and at necropsy (10 cases). A commercial fluorescent polyclonal antiserum of feline origin reacting with FIPV and cross reacting with transmissible gastroenteritis virus and canine coronavirus was used. Eleven cats with ascites of a different origin were used as negative controls. The direct immunofluorescence test was 97 per cent reliable (31 cases of 32) and can be used in routine diagnosis.
Summary In focal lesions of feline infectious peritonitis (FIP), the cells involved in the delayed‐type hypersensitivity were identified in formalin‐fixed paraffin‐embedded and frozen samples taken from 35 affected cats. The clinical diagnosis of FIP was confirmed by necropsy, histology and direct immunofluorescence against the coronaviruses on cryostatic sections. The immune cells were detected immunohistochemically by the Avidin‐Biotin‐Complex (ABC) method using either polyclonal antibodies against lymphoid antigens (CD3) or monoclonal antibodies against lymphoid (PAN‐T, CD4, CD8) and myeloid antigens (MAC387). Better identification of T cells and macrophages was found on formalin‐fixed paraffin‐embedded sections than on cryostatic ones, while T lymphocyte subpopulations could be differentiated only in cryostatic sections. Type IV hypersensitivity was detected in focal feline infectious peritonitis virus (FIPV)‐induced lesions from progressive activation of T lymphocytes, mainly CD4+, and the presence of granulocytes and macrophages. The FIPV‐induced lesions could be studied as examples of granulomas caused by unconventional antigens, such as viruses or immune complexes.
Thirty-three cases of Sertoli cell tumor, occurring in dogs of different breeds and ages, were studied histologically. Ectopic testes showed a particularly high tendency to develop the tumor. Metastases were not detected in regularly autopsied dogs nor reported or later ascertained for the bioptic consignments. According to Nielsen and Lein's classification (1974) our findings were divided as follows: 27 intratubular Sertoli cell tumors, 19 with stromal invasion and 8 without invasion; 2 diffuse tumors; 4 multiple primary tumors (3 Sertoli-seminoma cell tumor and 1 Sertoli-Leydig cell tumor). The above classification is discussed and proposed tentatively for revision.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.